Moolec Science (MLEC) has received a Notice of Allowance from the United States Patent and Trademark Office for its proprietary Piggy Sooy technology – soybean plant engineered to express high levels of porcine hemeproteins in their seeds. The U.S. patent covers the plants and seeds, the method used to develop them, and food compositions derived from this breakthrough innovation. In April 2024, the USDA-APHIS confirmed that Piggy Sooy does not present plant pest risk difference from conventional soybeans, determining it is not subject to regulation under 7 CFR part 340. This patent provides Moolec with exclusive commercial rights to Piggy Sooy technology in the U.S. until 2042.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLEC:
- Moolec Science Completes Strategic Business Combination to Enhance Life Sciences and Food-Tech Leadership
- Moolec Science announces closing of business combination
- Moolec Science Approves Key Business Combination at Extraordinary Meeting
- Moolec Science SA trading resumes
- Moolec Science SA trading halted, volatility trading pause
